Collaborations
We are a DRAP-Registered Clinical Trials Unit, recognized for meeting rigorous standards in the academic, ethical, and practical conduct of clinical research. This accreditation not only assures high-quality research but is also acknowledged by funding and regulatory bodies.
Conducting your study through CTU-RMI enhances your trial’s reliability, regulatory compliance, and visibility — significantly increasing the chances of successful execution, publication, and funding.
We aim to foster meaningful partnerships where investigators and CTU teams share expertise to deliver impactful research.
For collaboration inquiries, please 📧 Email us at: ctu@rmi.edu.pk
📞 Official Contact:+92-91-5838091
Frequently Asked Questions
We welcome proposals from internal or external investigators and sponsors, across phase III and IV trials, and both commercial and non-commercial studies, including:
- Clinical Trials (drug, device, interventional, observational)
- Well-Designed Studies in public health, outcomes research, or implementation science
- Standalone Pilot or Feasibility Trials, provided there’s a clear strategy to develop a definitive Phase III study
- Complex or High-Risk Trials, especially single-site trials needing expert operational support
- Academic/Student-Initiated Trials, with mentorship and guidance available
We recommend contacting us as early as possible during your project planning phase — ideally:
- When your research idea is taking shape and needs expert refinement
- When preparing grant proposals or applying for ethical/regulatory approvals
- When logistical, operational, or trial management support is required
- Before or during funding acquisition efforts
Early engagement allows our team to provide strategic input, improve proposal quality, and align timelines for smooth execution.
We’re here to make your research journey smooth and collaborative. To begin, please submit the following documents:
1. Synopsis
2. Full Study Protocol
3. Ethical Approval or Submission Proof
4. Funding Details or Intent
5. Regulatory Submissions (if applicable)
6. Formal Collaboration Request Letter
Our Collaborations







